Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Alzheimer's disease | R-HSA-1643685 | 0 | sulfadimidine | 667467 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | sulfadimidine | 667467 | drug-path |
Axon guidance | R-HSA-422475 | map04360 | sulfadimidine | 667467 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | sulfadimidine | 667467 | drug-path |
Melanoma | Q9UHD0-PRO_0000015379 | map05218 | sulfadimidine | 667467 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | sulfadimidine | 667467 | drug-path |
Glioma | Q9NZM4 | map05214 | ethoxyquin | 27447 | drug-path |
Renal cell carcinoma | R-HSA-9794523 | map05211 | ethoxyquin | 27447 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | ethoxyquin | 27447 | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | ethoxyquin | 27447 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | ethoxyquin | 27447 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | ethoxyquin | 27447 | drug-path |
Pancreatic cancer | R-HSA-9700206 | map05212 | ethoxyquin | 27447 | drug-path |
Prostate cancer | R-HSA-2990872 | map05215 | ethoxyquin | 27447 | drug-path |
Acute myeloid leukemia | R-HSA-9680350 | map05221 | ethoxyquin | 27447 | drug-path |
Bladder cancer | R-HSA-9700206 | map05219 | ethoxyquin | 27447 | drug-path |
Melanoma | Q9UHD0-PRO_0000015379 | map05218 | ethoxyquin | 27447 | drug-path |
ErbB signaling pathway | R-HSA-168638 | map04012 | ethoxyquin | 27447 | drug-path |
Non-small cell lung cancer | R-HSA-5619066 | map05223 | ethoxyquin | 27447 | drug-path |
Jak-STAT signaling pathway | R-HSA-168638 | map04630 | ethoxyquin | 27447 | drug-path |